Handelsbanken Fonder’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,851
| Closed | -$772K | – | 1501 |
|
|
2025
Q2 | $772K | Hold |
7,851
| – | – | ﹤0.01% | 1063 |
|
|
2025
Q1 | $727K | Hold |
7,851
| – | – | ﹤0.01% | 1078 |
|
|
2024
Q4 | $713K | Buy |
7,851
+1,600
| +26% | +$147K | ﹤0.01% | 1145 |
|
|
2024
Q3 | $603K | Hold |
6,251
| – | – | ﹤0.01% | 1167 |
|
|
2024
Q2 | $574K | Hold |
6,251
| – | – | ﹤0.01% | 1094 |
|
|
2024
Q1 | $576K | Hold |
6,251
| – | – | ﹤0.01% | 1098 |
|
|
2023
Q4 | $594K | Sell |
6,251
-97,800
| -94% | -$9.13M | ﹤0.01% | 1065 |
|
|
2023
Q3 | $9.72M | Hold |
104,051
| – | – | 0.05% | 321 |
|
|
2023
Q2 | $9.51M | Buy |
104,051
+15,000
| +17% | +$1.23M | 0.05% | 342 |
|
|
2023
Q1 | $6.55M | Hold |
89,051
| – | – | 0.04% | 378 |
|
|
2022
Q4 | $7.44M | Buy |
89,051
+17,500
| +24% | +$1.58M | 0.05% | 366 |
|
|
2022
Q3 | $6.92M | Buy |
71,551
+67,500
| +1,666% | +$8.05M | 0.05% | 351 |
|
|
2022
Q2 | $426K | Hold |
4,051
| – | – | ﹤0.01% | 1116 |
|
|
2022
Q1 | $698K | Sell |
4,051
-2,200
| -35% | -$329K | ﹤0.01% | 973 |
|
|
2021
Q4 | $1.01M | Sell |
6,251
-300
| -5% | -$48.2K | 0.01% | 884 |
|
|
2021
Q3 | $977K | Buy |
6,551
+1,300
| +25% | +$270K | 0.01% | 921 |
|
|
2021
Q2 | $1.29M | Sell |
5,251
-300
| -5% | -$78.7K | 0.01% | 789 |
|
|
2021
Q1 | $1.47M | Hold |
5,551
| – | – | 0.01% | 688 |
|
|
2020
Q4 | $1.63M | Hold |
5,551
| – | – | 0.01% | 652 |
|
|
2020
Q3 | $1.31M | Hold |
5,551
| – | – | 0.01% | 643 |
|
|
2020
Q2 | $1.1M | Buy |
+5,551
| New | +$1.04M | 0.01% | 657 |
|
Other funds holding AMED
IA
MCI
HNB
Handelsbanken Fonder's AMED Position: Q3 2025 in Review
Handelsbanken Fonder sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7,851 shares — an estimated $772K sold.
Handelsbanken Fonder first reported a position in AMED in Q2 2020 and held it in 21 quarters. The position peaked at $9.72M in Q3 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Handelsbanken Fonder reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Handelsbanken Fonder sold 7,851 Amedisys shares in Q3 2025, an estimated $772K.
- Handelsbanken Fonder first reported a position in Amedisys in Q2 2020 and held it in 21 quarters.
- Handelsbanken Fonder's Amedisys position peaked at $9.72M in Q3 2023.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Handelsbanken Fonder's 13F filing for Q3 2025, filed 12 Nov 2025.